Teresa Tarragó: “Crowdfunding is a Source of Financing for Early Stage Biotechs”

Teresa Tarragó: “Crowdfunding is a Source of Financing for Early Stage Biotechs”

Labcritics was at Iproteos’ facilities talking to Teresa Tarragó, CEO and co-founder of this innovative company. Iproteos combines computational chemistry with modern synthesis methods to generate peptidomimetics with pharmacological activity against diseases such as schizophrenia. We had the opportunity to know about the possibilities of crowdfunding for biotech projects and the technology used in their laboratory.

Visit iproteos.com

 

Labcritics Alerts / Sign-up to get alerts on discounts, new products, apps, protocols and breakthroughs in tools that help researchers succeed.

Reachout to Researchers with Our Extensive Marketing Network

Modern scientific marketing partner built for life science brands

Visit Labs Reach

Celestina is a science and medical writer specializing in creating clear, accurate, and engaging content across a range of deliverables, including manuscripts, newsletters, advisory board materials, infographics and promotional materials, tailored to healthcare professionals and scientific audiences. Her work spans diverse therapeutic areas such as oncology, ophthalmology, infectious diseases, cardiovascular health, rare diseases and more. With a Master’s in Infectious Diseases and a postgraduate diploma in Scientific Writing and Medical Journalism, I bring both scientific rigor and editorial precision to every project. Fluent in Mandarin, I also support the development and review of Traditional Chinese medical content to ensure scientific accuracy.

Similar Articles

First 3D Printed Drug Approved by FDA

 August 5, 2015